GENE ONLINE|News &
Opinion
Blog

Protein Degraders
Proxygen Eligible For €495 Million in Molecular Glue Degrader Collaboration with Merck KGaA
2022-06-06
SK Biopharma Teams Up with Targeted Protein Degrader Ubix
2022-04-15
Plexium Bags $102 Million for Targeted Protein Degraders
2022-02-24
Monte Rosa Bags $95 Million Series C Funding to Advance Protein Degraders
2021-03-14
SK Holdings Supports Roivant’s New Protein Degradation Platform with US$ 200 Million Investment
2020-12-13
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top